| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.097 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |